ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Celiac Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-26A9263
Home | Market Reports | Health| Nutrition
Global Celiac Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Celiac Drugs Market Research Report 2025

Code: QYRE-Auto-26A9263
Report
September 2025
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
ADMA Biologics
Amgen Inc
Anthera Pharmaceuticals
Bayer
Biogen
BioLineRx Ltd
Biotest
Bristol–Myers Squibb
Celgene
Celimmune
F.Hoffmann-La Roche
ImmunogenX
Immunomedics
ImmusanT
Innovate Biopharmaceuticals
Johnson & Johnson
Kedrion Biopharma
LFB Group
Merck
Novartis

Celiac Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Celiac Drugs Market

Celiac Drugs Market

The global market for Celiac Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Celiac disease, also known as celiac sprue or gluten-sensitive enteropathy, is a genetic autoimmune disorder caused due to the body’s inability to process gluten that causes damage to the small intestine. Gluten, a protein found in wheat, barley, and rye, can damage the lining of the small intestine which makes it difficult for the body to absorb nutrients such as iron, fat, calcium, and folate. The immune system mistakes substances inside gluten to be a threat to the body and attacks them, in turn, causing damage to the bowel surface and hampering the body’s ability to absorb nutrition. Digestion problems, dermatitis herpetiformis, abdominal pain, weight loss, musculoskeletal problems, aphthous ulcers, iron deficiency, stunted growth, tingling sensation in the leg, and missed menstrual cycles are some of the symptoms of celiac disease. The disease can lead to various complications and health problems such as miscarriage or infertility, intestinal cancer, osteoporosis, seizures, gall bladder malfunction, neurological manifestation of the disease, stunted growth in children, and birth defects. Celiac disease can also lead to various autoimmune diseases such as lupus, thyroid disease, Sjögren"s syndrome, type 1 diabetes, and rheumatoid arthritis. It is difficult to diagnose celiac disease in the initial stages as its symptoms are similar to those of other diseases. Various sensitive and selective blood tests such as anti-tissue transglutaminase antibodies with or without IgA level and IgA anti-endomysial antibodies are used to screen the disease.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Celiac Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Celiac Drugs.
The Celiac Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Celiac Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Celiac Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Celiac Drugs Market Report

Report Metric Details
Report Name Celiac Drugs Market
CAGR 5%
Segment by Type
  • First Line Of Treatment
  • Second Line Of Treatment
Segment by Application
  • Men
  • Women
  • Children
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company ADMA Biologics, Amgen, Anthera Pharmaceuticals, Bayer, Biogen, BioLineRx, Biotest, Bristol-Myers Squibb, Celgene, Celimmune, F Hoffmann-La Roche, ImmunogenX, Immunomedics, ImmusanT, Innovate Biopharmaceuticals, Johnson & Johnson, Kedrion Biopharma, LFB Group, Merck, Novartis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Celiac Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Celiac Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Celiac Drugs Market report?

Ans: The main players in the Celiac Drugs Market are ADMA Biologics, Amgen, Anthera Pharmaceuticals, Bayer, Biogen, BioLineRx, Biotest, Bristol-Myers Squibb, Celgene, Celimmune, F Hoffmann-La Roche, ImmunogenX, Immunomedics, ImmusanT, Innovate Biopharmaceuticals, Johnson & Johnson, Kedrion Biopharma, LFB Group, Merck, Novartis

What are the Application segmentation covered in the Celiac Drugs Market report?

Ans: The Applications covered in the Celiac Drugs Market report are Men, Women, Children

What are the Type segmentation covered in the Celiac Drugs Market report?

Ans: The Types covered in the Celiac Drugs Market report are First Line Of Treatment, Second Line Of Treatment

1 Celiac Drugs Market Overview
1.1 Product Definition
1.2 Celiac Drugs by Type
1.2.1 Global Celiac Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 First Line Of Treatment
1.2.3 Second Line Of Treatment
1.3 Celiac Drugs by Application
1.3.1 Global Celiac Drugs Market Value by Application (2024 VS 2031)
1.3.2 Men
1.3.3 Women
1.3.4 Children
1.4 Global Celiac Drugs Market Size Estimates and Forecasts
1.4.1 Global Celiac Drugs Revenue 2020-2031
1.4.2 Global Celiac Drugs Sales 2020-2031
1.4.3 Global Celiac Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Celiac Drugs Market Competition by Manufacturers
2.1 Global Celiac Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Celiac Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Celiac Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Celiac Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Celiac Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Celiac Drugs, Product Type & Application
2.7 Global Key Manufacturers of Celiac Drugs, Date of Enter into This Industry
2.8 Global Celiac Drugs Market Competitive Situation and Trends
2.8.1 Global Celiac Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Celiac Drugs Players Market Share by Revenue
2.8.3 Global Celiac Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Celiac Drugs Market Scenario by Region
3.1 Global Celiac Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Celiac Drugs Sales by Region: 2020-2031
3.2.1 Global Celiac Drugs Sales by Region: 2020-2025
3.2.2 Global Celiac Drugs Sales by Region: 2026-2031
3.3 Global Celiac Drugs Revenue by Region: 2020-2031
3.3.1 Global Celiac Drugs Revenue by Region: 2020-2025
3.3.2 Global Celiac Drugs Revenue by Region: 2026-2031
3.4 North America Celiac Drugs Market Facts & Figures by Country
3.4.1 North America Celiac Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Celiac Drugs Sales by Country (2020-2031)
3.4.3 North America Celiac Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Celiac Drugs Market Facts & Figures by Country
3.5.1 Europe Celiac Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Celiac Drugs Sales by Country (2020-2031)
3.5.3 Europe Celiac Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Celiac Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Celiac Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Celiac Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Celiac Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Celiac Drugs Market Facts & Figures by Country
3.7.1 Latin America Celiac Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Celiac Drugs Sales by Country (2020-2031)
3.7.3 Latin America Celiac Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Celiac Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Celiac Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Celiac Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Celiac Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Celiac Drugs Sales by Type (2020-2031)
4.1.1 Global Celiac Drugs Sales by Type (2020-2025)
4.1.2 Global Celiac Drugs Sales by Type (2026-2031)
4.1.3 Global Celiac Drugs Sales Market Share by Type (2020-2031)
4.2 Global Celiac Drugs Revenue by Type (2020-2031)
4.2.1 Global Celiac Drugs Revenue by Type (2020-2025)
4.2.2 Global Celiac Drugs Revenue by Type (2026-2031)
4.2.3 Global Celiac Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Celiac Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Celiac Drugs Sales by Application (2020-2031)
5.1.1 Global Celiac Drugs Sales by Application (2020-2025)
5.1.2 Global Celiac Drugs Sales by Application (2026-2031)
5.1.3 Global Celiac Drugs Sales Market Share by Application (2020-2031)
5.2 Global Celiac Drugs Revenue by Application (2020-2031)
5.2.1 Global Celiac Drugs Revenue by Application (2020-2025)
5.2.2 Global Celiac Drugs Revenue by Application (2026-2031)
5.2.3 Global Celiac Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Celiac Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 ADMA Biologics
6.1.1 ADMA Biologics Company Information
6.1.2 ADMA Biologics Description and Business Overview
6.1.3 ADMA Biologics Celiac Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 ADMA Biologics Celiac Drugs Product Portfolio
6.1.5 ADMA Biologics Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Company Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Celiac Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Amgen Celiac Drugs Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Anthera Pharmaceuticals
6.3.1 Anthera Pharmaceuticals Company Information
6.3.2 Anthera Pharmaceuticals Description and Business Overview
6.3.3 Anthera Pharmaceuticals Celiac Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Anthera Pharmaceuticals Celiac Drugs Product Portfolio
6.3.5 Anthera Pharmaceuticals Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Company Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Celiac Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bayer Celiac Drugs Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Biogen
6.5.1 Biogen Company Information
6.5.2 Biogen Description and Business Overview
6.5.3 Biogen Celiac Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Biogen Celiac Drugs Product Portfolio
6.5.5 Biogen Recent Developments/Updates
6.6 BioLineRx
6.6.1 BioLineRx Company Information
6.6.2 BioLineRx Description and Business Overview
6.6.3 BioLineRx Celiac Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BioLineRx Celiac Drugs Product Portfolio
6.6.5 BioLineRx Recent Developments/Updates
6.7 Biotest
6.7.1 Biotest Company Information
6.7.2 Biotest Description and Business Overview
6.7.3 Biotest Celiac Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Biotest Celiac Drugs Product Portfolio
6.7.5 Biotest Recent Developments/Updates
6.8 Bristol-Myers Squibb
6.8.1 Bristol-Myers Squibb Company Information
6.8.2 Bristol-Myers Squibb Description and Business Overview
6.8.3 Bristol-Myers Squibb Celiac Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bristol-Myers Squibb Celiac Drugs Product Portfolio
6.8.5 Bristol-Myers Squibb Recent Developments/Updates
6.9 Celgene
6.9.1 Celgene Company Information
6.9.2 Celgene Description and Business Overview
6.9.3 Celgene Celiac Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Celgene Celiac Drugs Product Portfolio
6.9.5 Celgene Recent Developments/Updates
6.10 Celimmune
6.10.1 Celimmune Company Information
6.10.2 Celimmune Description and Business Overview
6.10.3 Celimmune Celiac Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Celimmune Celiac Drugs Product Portfolio
6.10.5 Celimmune Recent Developments/Updates
6.11 F Hoffmann-La Roche
6.11.1 F Hoffmann-La Roche Company Information
6.11.2 F Hoffmann-La Roche Description and Business Overview
6.11.3 F Hoffmann-La Roche Celiac Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 F Hoffmann-La Roche Celiac Drugs Product Portfolio
6.11.5 F Hoffmann-La Roche Recent Developments/Updates
6.12 ImmunogenX
6.12.1 ImmunogenX Company Information
6.12.2 ImmunogenX Description and Business Overview
6.12.3 ImmunogenX Celiac Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 ImmunogenX Celiac Drugs Product Portfolio
6.12.5 ImmunogenX Recent Developments/Updates
6.13 Immunomedics
6.13.1 Immunomedics Company Information
6.13.2 Immunomedics Description and Business Overview
6.13.3 Immunomedics Celiac Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Immunomedics Celiac Drugs Product Portfolio
6.13.5 Immunomedics Recent Developments/Updates
6.14 ImmusanT
6.14.1 ImmusanT Company Information
6.14.2 ImmusanT Description and Business Overview
6.14.3 ImmusanT Celiac Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 ImmusanT Celiac Drugs Product Portfolio
6.14.5 ImmusanT Recent Developments/Updates
6.15 Innovate Biopharmaceuticals
6.15.1 Innovate Biopharmaceuticals Company Information
6.15.2 Innovate Biopharmaceuticals Description and Business Overview
6.15.3 Innovate Biopharmaceuticals Celiac Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Innovate Biopharmaceuticals Celiac Drugs Product Portfolio
6.15.5 Innovate Biopharmaceuticals Recent Developments/Updates
6.16 Johnson & Johnson
6.16.1 Johnson & Johnson Company Information
6.16.2 Johnson & Johnson Description and Business Overview
6.16.3 Johnson & Johnson Celiac Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Johnson & Johnson Celiac Drugs Product Portfolio
6.16.5 Johnson & Johnson Recent Developments/Updates
6.17 Kedrion Biopharma
6.17.1 Kedrion Biopharma Company Information
6.17.2 Kedrion Biopharma Description and Business Overview
6.17.3 Kedrion Biopharma Celiac Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Kedrion Biopharma Celiac Drugs Product Portfolio
6.17.5 Kedrion Biopharma Recent Developments/Updates
6.18 LFB Group
6.18.1 LFB Group Company Information
6.18.2 LFB Group Description and Business Overview
6.18.3 LFB Group Celiac Drugs Sales, Revenue and Gross Margin (2020-2025)
6.18.4 LFB Group Celiac Drugs Product Portfolio
6.18.5 LFB Group Recent Developments/Updates
6.19 Merck
6.19.1 Merck Company Information
6.19.2 Merck Description and Business Overview
6.19.3 Merck Celiac Drugs Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Merck Celiac Drugs Product Portfolio
6.19.5 Merck Recent Developments/Updates
6.20 Novartis
6.20.1 Novartis Company Information
6.20.2 Novartis Description and Business Overview
6.20.3 Novartis Celiac Drugs Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Novartis Celiac Drugs Product Portfolio
6.20.5 Novartis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Celiac Drugs Industry Chain Analysis
7.2 Celiac Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Celiac Drugs Production Mode & Process Analysis
7.4 Celiac Drugs Sales and Marketing
7.4.1 Celiac Drugs Sales Channels
7.4.2 Celiac Drugs Distributors
7.5 Celiac Drugs Customer Analysis
8 Celiac Drugs Market Dynamics
8.1 Celiac Drugs Industry Trends
8.2 Celiac Drugs Market Drivers
8.3 Celiac Drugs Market Challenges
8.4 Celiac Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
ADMA Biologics
Amgen Inc
Anthera Pharmaceuticals
Bayer
Biogen
BioLineRx Ltd
Biotest
Bristol–Myers Squibb
Celgene
Celimmune
F.Hoffmann-La Roche
ImmunogenX
Immunomedics
ImmusanT
Innovate Biopharmaceuticals
Johnson & Johnson
Kedrion Biopharma
LFB Group
Merck
Novartis
List of Tables
 Table 1. Global Celiac Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Celiac Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Celiac Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Celiac Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Celiac Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Celiac Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Celiac Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Celiac Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Celiac Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Celiac Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Celiac Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Celiac Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Celiac Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Celiac Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Celiac Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Celiac Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Celiac Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Celiac Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Celiac Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Celiac Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Celiac Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Celiac Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Celiac Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Celiac Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Celiac Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Celiac Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Celiac Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Celiac Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Celiac Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Celiac Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Celiac Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Celiac Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Celiac Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Celiac Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Celiac Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Celiac Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Celiac Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Celiac Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Celiac Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Celiac Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Celiac Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Celiac Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Celiac Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Celiac Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Celiac Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Celiac Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Celiac Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Celiac Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Celiac Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Celiac Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Celiac Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Celiac Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Celiac Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Celiac Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Celiac Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Celiac Drugs Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Celiac Drugs Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Celiac Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Celiac Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Celiac Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Celiac Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Celiac Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Celiac Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Celiac Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Celiac Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Celiac Drugs Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Celiac Drugs Price (USD/Unit) by Application (2026-2031)
 Table 70. ADMA Biologics Company Information
 Table 71. ADMA Biologics Description and Business Overview
 Table 72. ADMA Biologics Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. ADMA Biologics Celiac Drugs Product
 Table 74. ADMA Biologics Recent Developments/Updates
 Table 75. Amgen Company Information
 Table 76. Amgen Description and Business Overview
 Table 77. Amgen Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Amgen Celiac Drugs Product
 Table 79. Amgen Recent Developments/Updates
 Table 80. Anthera Pharmaceuticals Company Information
 Table 81. Anthera Pharmaceuticals Description and Business Overview
 Table 82. Anthera Pharmaceuticals Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Anthera Pharmaceuticals Celiac Drugs Product
 Table 84. Anthera Pharmaceuticals Recent Developments/Updates
 Table 85. Bayer Company Information
 Table 86. Bayer Description and Business Overview
 Table 87. Bayer Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Bayer Celiac Drugs Product
 Table 89. Bayer Recent Developments/Updates
 Table 90. Biogen Company Information
 Table 91. Biogen Description and Business Overview
 Table 92. Biogen Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Biogen Celiac Drugs Product
 Table 94. Biogen Recent Developments/Updates
 Table 95. BioLineRx Company Information
 Table 96. BioLineRx Description and Business Overview
 Table 97. BioLineRx Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. BioLineRx Celiac Drugs Product
 Table 99. BioLineRx Recent Developments/Updates
 Table 100. Biotest Company Information
 Table 101. Biotest Description and Business Overview
 Table 102. Biotest Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Biotest Celiac Drugs Product
 Table 104. Biotest Recent Developments/Updates
 Table 105. Bristol-Myers Squibb Company Information
 Table 106. Bristol-Myers Squibb Description and Business Overview
 Table 107. Bristol-Myers Squibb Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Bristol-Myers Squibb Celiac Drugs Product
 Table 109. Bristol-Myers Squibb Recent Developments/Updates
 Table 110. Celgene Company Information
 Table 111. Celgene Description and Business Overview
 Table 112. Celgene Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Celgene Celiac Drugs Product
 Table 114. Celgene Recent Developments/Updates
 Table 115. Celimmune Company Information
 Table 116. Celimmune Description and Business Overview
 Table 117. Celimmune Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Celimmune Celiac Drugs Product
 Table 119. Celimmune Recent Developments/Updates
 Table 120. F Hoffmann-La Roche Company Information
 Table 121. F Hoffmann-La Roche Description and Business Overview
 Table 122. F Hoffmann-La Roche Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. F Hoffmann-La Roche Celiac Drugs Product
 Table 124. F Hoffmann-La Roche Recent Developments/Updates
 Table 125. ImmunogenX Company Information
 Table 126. ImmunogenX Description and Business Overview
 Table 127. ImmunogenX Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. ImmunogenX Celiac Drugs Product
 Table 129. ImmunogenX Recent Developments/Updates
 Table 130. Immunomedics Company Information
 Table 131. Immunomedics Description and Business Overview
 Table 132. Immunomedics Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Immunomedics Celiac Drugs Product
 Table 134. Immunomedics Recent Developments/Updates
 Table 135. ImmusanT Company Information
 Table 136. ImmusanT Description and Business Overview
 Table 137. ImmusanT Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 138. ImmusanT Celiac Drugs Product
 Table 139. ImmusanT Recent Developments/Updates
 Table 140. Innovate Biopharmaceuticals Company Information
 Table 141. Innovate Biopharmaceuticals Description and Business Overview
 Table 142. Innovate Biopharmaceuticals Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 143. Innovate Biopharmaceuticals Celiac Drugs Product
 Table 144. Innovate Biopharmaceuticals Recent Developments/Updates
 Table 145. Johnson & Johnson Company Information
 Table 146. Johnson & Johnson Description and Business Overview
 Table 147. Johnson & Johnson Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 148. Johnson & Johnson Celiac Drugs Product
 Table 149. Johnson & Johnson Recent Developments/Updates
 Table 150. Kedrion Biopharma Company Information
 Table 151. Kedrion Biopharma Description and Business Overview
 Table 152. Kedrion Biopharma Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 153. Kedrion Biopharma Celiac Drugs Product
 Table 154. Kedrion Biopharma Recent Developments/Updates
 Table 155. LFB Group Company Information
 Table 156. LFB Group Description and Business Overview
 Table 157. LFB Group Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 158. LFB Group Celiac Drugs Product
 Table 159. LFB Group Recent Developments/Updates
 Table 160. Merck Company Information
 Table 161. Merck Description and Business Overview
 Table 162. Merck Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 163. Merck Celiac Drugs Product
 Table 164. Merck Recent Developments/Updates
 Table 165. Novartis Company Information
 Table 166. Novartis Description and Business Overview
 Table 167. Novartis Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 168. Novartis Celiac Drugs Product
 Table 169. Novartis Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. Celiac Drugs Distributors List
 Table 173. Celiac Drugs Customers List
 Table 174. Celiac Drugs Market Trends
 Table 175. Celiac Drugs Market Drivers
 Table 176. Celiac Drugs Market Challenges
 Table 177. Celiac Drugs Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Celiac Drugs
 Figure 2. Global Celiac Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Celiac Drugs Market Share by Type: 2024 & 2031
 Figure 4. First Line Of Treatment Product Picture
 Figure 5. Second Line Of Treatment Product Picture
 Figure 6. Global Celiac Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Celiac Drugs Market Share by Application: 2024 & 2031
 Figure 8. Men
 Figure 9. Women
 Figure 10. Children
 Figure 11. Global Celiac Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Celiac Drugs Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Celiac Drugs Sales (2020-2031) & (K Units)
 Figure 14. Global Celiac Drugs Average Price (USD/Unit) & (2020-2031)
 Figure 15. Celiac Drugs Report Years Considered
 Figure 16. Celiac Drugs Sales Share by Manufacturers in 2024
 Figure 17. Global Celiac Drugs Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Celiac Drugs Players: Market Share by Revenue in Celiac Drugs in 2024
 Figure 19. Celiac Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Celiac Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Celiac Drugs Sales Market Share by Country (2020-2031)
 Figure 22. North America Celiac Drugs Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Celiac Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Celiac Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Celiac Drugs Sales Market Share by Country (2020-2031)
 Figure 26. Europe Celiac Drugs Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Celiac Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Celiac Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Celiac Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Celiac Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Celiac Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Celiac Drugs Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Celiac Drugs Revenue Market Share by Region (2020-2031)
 Figure 34. China Celiac Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Celiac Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Celiac Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Celiac Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Celiac Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Celiac Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Celiac Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Celiac Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Celiac Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Celiac Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Celiac Drugs Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Celiac Drugs Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Celiac Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Celiac Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Celiac Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Celiac Drugs Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Celiac Drugs Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Celiac Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Celiac Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Celiac Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Celiac Drugs by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Celiac Drugs by Type (2020-2031)
 Figure 56. Global Celiac Drugs Price (USD/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Celiac Drugs by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Celiac Drugs by Application (2020-2031)
 Figure 59. Global Celiac Drugs Price (USD/Unit) by Application (2020-2031)
 Figure 60. Celiac Drugs Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Celiac Test Market Research Report 2025
Celiac Disease Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Celiac Disease Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gluten Intolerance Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gluten Tolerance Test Kit Market Research Report 2025
Global Gluten Free Food Market Research Report 2025
Global Non Gluten Products Market Insights Forecast to 2030
Global Non Gluten Foods Market Insights Forecast to 2030
Gastrointestinal Disorder Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Corn Gluten Market Research Report 2025
Global Disease Risk and Health Genetic Test Market Insights Forecast to 2030
Global Disease Risk and Health Test Market Insights Forecast to 2030
Global Digestive Distress Treatment Market Research Report 2024
Global Direct to consumer Disease Risk and Health Test Market Insights Forecast to 2030
Global Gluten Protein Market Research Report 2024
Global Totally Gluten Free Products Market Research Report 2024
Global Gluten Free Bread Products Market Outlook 2021
Gluten free Pet Food Market
Global Gastrointestinal Drugs Market Research Report 2025
Global Protein Losing Enteropathy Medication Market Research Report 2024

RELATED REPORTS

Global Pet Heart Support Supplement Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32R16607
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Upright Medical Freezer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Z16914
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Enteral Nutrition and Parenteral Nutrition Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Y16395
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Supplements for PCOS Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22K16338
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions